Skip to content

Effects of Motivational Interviewing for Long-term Sick Absence

Effects of Motivational Interviewing for Long-term Sick Absence: A Randomized Controlled Trial With Mixed Methods

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03212118
Enrollment
774
Registered
2017-07-11
Start date
2018-01-01
Completion date
2022-07-01
Last updated
2022-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sick Leave

Keywords

Sick Leave, Return to work, Motivational interviewing, Absenteeism, Occupational Health

Brief summary

Long-term sickness absence has considerable impact on social functioning, families involved, the employer, and society as a whole. Preventing long-term sickness absence and increase the likelihood of return to work (RTW) are critical concerns for industrialized countries across the world. Motivational factors contributing to RTW and maintenance of work participation are therefore of importance to explore in order to get the person back to work after long-term sick leave. Motivational interviewing (MI) is an empirically validated psychological approach that may be particularly useful in a RTW context. Even though MI has been widely studied and is considered a flexible intervention strategy in different domains, its effectiveness in improving RTW has not yet been studied. The aim of this study is to evaluate whether MI provided by trained caseworkers at The Norwegian Labour and Welfare Administration (NAV) to sick-listed users with unselected diagnoses facilitates RTW compared with follow-up as usual.

Detailed description

The main study will be preceded by a pilot study (anticipated start medio august 2017). The aim of the pilot is to test the practical aspects of the study. If no changes are made to the study protocol, the intervention or one of the other arms, participants from the pilot will be included in the main study, In case of modifications to the study protocol after the pilot, participants from the pilot study will not be included in the main study. Data for primary and secondary outcomes will not be assessed before the end of the main study. In addition to the intention to treat and per protocol analyses, subgroup analyses will be performed if sufficient power for age, gender, diagnoses for sick leave, occupational category and length of previous sick leave. In addition to the effect evaluation, qualitative studies, a feasibility/process evaluation study and a health economic evaluation (cost-effectiveness, cost-utility and cost-benefit) will be performed. The qualitative studies will be based on data from focus group discussions. The main areas for investigation will be: * The participants' expectations to return to work before and after motivational interviewing. * Perceived facilitators and obstacles for return to work among participants * The perceived benefits and challenges in using motivational interview to facilitate a return to work process Changes made Sept.29 2017: Due to slow recruitment, it was decided to leave out one of the arms from the study (TAU-1: extra phone call to employer). The extra phone call element was also taken out from the other arms where it was included. Another reason for this change was that the TAU-1 intervention arm was not ideally designed to evaluate the extra phone call. It was decided this intervention arm is better evaluated in a separate trial. Currently 12 persons are included and randomized in the trial. Those who are randomized to TAU-1 and have not received an intervention, will be randomized again. The ones randomized to TAU-1 who already have got an intervention will stop participating in the study. Changes made Aug. 26 2019: Due to problems with implementation of the intervervention the first couple of months, it was decided to start inclusion from Jan 1st 2018 (instead of Aug 2017). The planned number of participants has not changed. Clarification added April 25 2021. Regarding exclusion criterion unemployment: only sick listed individuals listed with an employer were identified in the sick leave registries and invited to take part in the study. That means individuals who were unemployed, self-employed or for other reasons without an employer were not included.

Interventions

BEHAVIORALTreatment as usual (TAU-0)

The standard NAV procedure, which consists of a telephone call within 8 weeks to an employer who have employees on 100% sick leave, in addition to regular NAV conversations on-demand (not fixed intervals) between the NAV caseworkers and the employees.

BEHAVIORALStructured talks (TAU-2)

Two structured talks (not including elements from motivational interviewing)

BEHAVIORALmotivational interviewing (MI)

Two structured talks (must have a valid motivational interviewing content).

Sponsors

University of Bergen
CollaboratorOTHER
University of Oslo
CollaboratorOTHER
National Center for Occupational Rehabilitation, Rauland
CollaboratorUNKNOWN
Deakin University
CollaboratorOTHER
Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Living in the county Sør-Trøndelag * On sick leave for 8 weeks * Current sick leave status of 50-100%

Exclusion criteria

* no employment * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Total number of sickness absence days during the year after enrollment in the study (i.e. after randomization)12 monthsRegister data from the national health and welfare services

Secondary

MeasureTime frameDescription
Probability of working (i.e. not receiving medical benefits) each month during follow-up, measured as repeated events12 monthsRegister data from the national health and welfare services
Return to Work Self-Efficacy12 monthsReturn to Work Self-Efficacy Scale (Lagerveld et al, 2010)
Resilience12 monthsResilience Scale for Adults (Friborg et al, 2003)
Return to work expectations12 monthsExpectations about length of sick leave and return to work (3 items)
Workability12 monthsSingle question. How will you rate your work ability (scale from 0 (no ability) to 10 (my best ability)) (1 item)
Health-related quality of life12 monthsEQ- 5D- 5L Questionnaire, Herdman et al, 2011
The time until full sustainable return to work (RTW), i.e. for at least 4 weeks without relapse12 monthsRegister data from the national health and welfare services

Other

MeasureTime frameDescription
Sleep problems12 monthsInsomnia Severity Index, 5 items
Anxiety symptoms12 monthsGeneralized Anxiety Disorder 7-item (GAD-7)
Depression symptoms12 monthsPatient Health Questionnaire (PHQ-9)
Fatigue12 monthsFatigue Severity Scale (FFS), 1 item
Pain12 monthsBrief Pain Inventory (BPI), 1 item

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026